Download presentation
Presentation is loading. Please wait.
Published byDarcy Morris Modified over 9 years ago
1
Bio Trunking Antimicrobial Trunking Solutions from Marshall-Tufflex
2
Infection control – the challenges Reduction in the transfer of microorganisms is a key objective for the NHS. Why? –There are 300,000 hospital associated infections (HCAIs) in the UK per year. –There is a £270m investment in infection control per year. –HCAIs actually cost £1bn and 5,000 deaths per year. Per person - 11 extra days in hospital and 3 times the cost!
3
Infection control – prevention Where hygiene is a priority: –Providing a reduction in the transfer of bacteria via inanimate objects. –Antimicrobial PVC-U trunking supports other infection control initiatives. –It also helps to prevent discolouration and odour formation on the treated item. Prevention is better than cure!
4
Infection control – why silver? Silver has been used for centuries to inhibit the growth of bacteria. Silver ions: –Provide controlled delivery –Are thermally stable –Inorganic –Non-leachable –Registration with the Environmental Protection Agency (EPA) –Compliance with the European Products Directive (BPD). AG +
5
Silver – how it works Silver ions attack bacterial cells in contact with a surface. Solutions integral within the PVC-U provide consistent antibacterial performance. Controlled release over product life. Ag + Bacterial Cells
6
Bio Trunking - testing MRSA Quantitative Assessment of Activity – ISO 22196:2007 MRSA Concentration of starting inoculum4.94 x 10 5 CFU/mL Sample Description No. Bacteria Recovered Log Value R = [log(B/C)] % Survival 1. Flat profile – Blue Tape, White PVC – untreated control 7.19 x 10 6 6.9------ 2. Curved profile – Red Tape, White PVC – Treated with Ultra-Fresh CA-16 <2.00 x 10 1 <1.3>5.6<0.1% The treated curved profile (Sample 2) showed excellent control of MRSA with a greater than 99.9% reduction in bacteria compared to the untreated flat profile (Sample 1). TEST RESULTS: Marshall-Tufflex Report #2422431 LABORATORY: Thornton Research Associates Inc., Ontario, Canada TEST ORGANISM: Methicillin Resistant Staphylococcus Aureus (MRSA) Tests made in conjunction with material suppliers Doeflex-Ultrafresh
7
Bio Trunking – testing K. pneumoniae TEST RESULTS: Marshall-Tufflex Report #2422435 LABORATORY: Thornton Research Associates Inc., Ontario, Canada TEST ORGANISM: Klebsiella Pneumoniae Quantitative Assessment of Activity – ISO 22196:2007 K. pneumoniae Concentration of starting inoculum1.16 x 10 5 CFU/mL Sample Description No. Bacteria Recover ed Log ValueR = [log(B/C)]% Survival 1. Flat profile – Blue Tape, White PVC – untreated control 3.06 x 10 6 6.5------ 2. Curved profile – Red Tape, White PVC – Treated with Ultra-Fresh CA- 16 4.01 x 10 2 2.63.9<0.1% The treated curved profile (Sample 2) showed excellent control of Klebsiella Pneumoniae with a greater than 99.9% reduction in bacteria compared to the untreated flat profile (Sample 1). The bacteria grew on the untreated sample.
8
Bio Trunking Solutions Derriford Hospital, Plymouth Odyssey Bio in 11 operating theatres. “Odyssey Bio…is a product that is likely to come to the fore in the control of infection as Trusts up and down the country tackle the continuing threat of virulent infectious diseases.” Rob Ellis, Head of Electrical Estates, Plymouth NHS Trust.
9
Heavitree Hospital Odyssey Bio for the Dermatology & Lymphoedema Unit “ Infection control was the over- riding factor in the specification of Odyssey Bio. It is a superb product and we are very pleased with it.” Royal Devon & Exeter NHS Trust
10
A range of trunking systems with integral antimicrobial properties. - Prevents 99.9% of harmful bacteria growth. - No reduction in effectiveness if the trunking is damaged. - Tests to ISO 22196:2007 Bio Trunking Solutions a caring choice for the healthcare environment Marshall-Tufflex Bio Trunking Solutions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.